Akademik Veri Yönetim Sistemi
20th WONCA Europe Conference 2015 Istanbul, October 22-25 2015, İstanbul, Türkiye, 22 - 25 Ekim 2015, cilt.1, ss.1085-1086
AIM: Identifying the
most effective intervention for behaviour change in smoking cessation is still
a matter of interest in scientific research. The research question is: Does
informing patients about the mechanisms of developing nicotine addiction and
the mode of action of the drug they are prescribed to quit smoking
(varenicline) change the outcome of smoking cessation rates compared to
patients who were prescribed varenicline and were subject to brief intervention
about smoking cessation?
METHOD: Patients who
presented to two periodic health examination outpatient clinics run by family
physicians at a private hospital are eligible for this study. Inclusion
criteria is smoking more than 10 cigarettes a day for the last consecutive year
and giving informed consent. Exclusion criteria were diagnosis of mental
disorders (e.g. depression, bipolar disorder). At outpatient clinic A the
patients will be given brief intervention about smoking cessation and
prescribed varenicline (control group). At outpatient clinic B patients will be
prescribed varenicline and given additional information about the way nicotine
dependence is developed and the mode of action of the drug they are prescribed
to assist them quit smoking (varenicline) (intervention group). Patients will
be assigned to intervention and control systematically by the receptionists of
the hospital who give the appointments for the outpatient clinic visits.
Primary outcome parameter will be smoking cessation rates of patients in both
groups after six months. Sample size will be calculated to compute an estimated
difference of smoking rates between two groups (α<0,05, 1-ß 0,8, 95% CI).
The estimated value will be extracted from the review of the recent relevant
literature.
RESULTS: There are no
results, yet. They will be ready at the conference' time. Keywords: smoking
cessation, preventional medicine, behavioral treatments Figure 1: Outcome by
Intervention and Drug Therapy
Table 1: General
Characteristics of the Study Population
Sex: male (n, %)
Age (years, mean±SD)
Marital status:
married (n, %)
Education:
high education (n, %)
Occupation:
white collar-academicians (n,%)
Comorbidity (n, %)
82 59,9%
45,6±10
105 76,6%
86 62,8%
91 66,4%
24 17,5%
44 32,5%
21,4+-14,2
Symptomatic (n, %)
Exposure to smoking in pack years (mean+-SD)